Company Filing History:
1 out of 2,106 
1 out of 87 
Years Active: 2025
Title: Ian Cardle: Innovator in Aptamer Technology
Introduction
Ian Cardle is a notable inventor based in Seattle, Washington. He has made significant contributions to the field of biotechnology, particularly in the development of aptamers that target immune cells. His work has implications for therapeutic applications and drug delivery systems.
Latest Patents
Ian Cardle holds a patent titled "Monocyte and macrophage binding aptamers and their application." This patent describes compositions that include aptamers specifically designed to bind to monocytes and macrophages. The methods outlined in the patent can be utilized for isolating, enriching, or depleting these cell populations. The aptamer compositions have potential applications in therapies and drug delivery.
Career Highlights
Throughout his career, Ian has worked with prestigious institutions such as the University of Washington and Seattle Children's Hospital. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Ian has collaborated with esteemed colleagues, including Suzie H Pun and Meilyn Sylvestre. These partnerships have fostered innovation and enhanced the impact of his research.
Conclusion
Ian Cardle's work in aptamer technology represents a significant advancement in the field of biotechnology. His contributions have the potential to improve therapeutic strategies and drug delivery systems.